HCA Healthcare, Inc. $HCA Shares Sold by Harrell Investment Partners LLC

Harrell Investment Partners LLC lessened its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 63.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 660 shares of the company’s stock after selling 1,155 shares during the period. Harrell Investment Partners LLC’s holdings in HCA Healthcare were worth $281,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of HCA. Kingswood Wealth Advisors LLC grew its stake in HCA Healthcare by 63.0% during the third quarter. Kingswood Wealth Advisors LLC now owns 4,882 shares of the company’s stock worth $2,081,000 after buying an additional 1,887 shares during the period. Strategic Planning Group LLC increased its holdings in HCA Healthcare by 47.8% in the 3rd quarter. Strategic Planning Group LLC now owns 21,165 shares of the company’s stock valued at $9,021,000 after purchasing an additional 6,848 shares in the last quarter. Benjamin Edwards Inc. lifted its stake in shares of HCA Healthcare by 76.7% during the third quarter. Benjamin Edwards Inc. now owns 1,283 shares of the company’s stock worth $547,000 after purchasing an additional 557 shares in the last quarter. HB Wealth Management LLC grew its stake in shares of HCA Healthcare by 30.4% in the third quarter. HB Wealth Management LLC now owns 6,876 shares of the company’s stock valued at $2,931,000 after buying an additional 1,601 shares in the last quarter. Finally, Caldwell Trust Co boosted its holdings in HCA Healthcare by 5.0% in the 3rd quarter. Caldwell Trust Co now owns 1,311 shares of the company’s stock worth $559,000 after acquiring an additional 63 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In other news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several research firms have issued reports on HCA. The Goldman Sachs Group lifted their price target on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Oppenheimer boosted their target price on HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a research note on Monday, October 27th. Royal Bank Of Canada lifted their price target on HCA Healthcare from $482.00 to $525.00 and gave the company an “outperform” rating in a report on Friday, December 19th. Morgan Stanley cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price for the company. in a research note on Monday, December 15th. Finally, Zacks Research lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. Fourteen research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $485.95.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $479.29 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $295.00 and a fifty-two week high of $520.00. The company has a market capitalization of $109.37 billion, a price-to-earnings ratio of 18.53, a P/E/G ratio of 1.29 and a beta of 1.36. The firm’s 50 day simple moving average is $479.63 and its 200 day simple moving average is $426.40.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period last year, the firm posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Monday, December 15th. HCA Healthcare’s dividend payout ratio is presently 11.13%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.